Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.2824 | 0.2122 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.4141 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 1 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.4141 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0016 | 0.2208 | 0.2208 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0038 | 0.8067 | 0.7878 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0016 | 0.2208 | 0.312 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.4141 | 0.3568 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.2208 | 0.2208 |
Brugia malayi | polk-prov protein | 0.0034 | 0.7075 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.2208 | 0.312 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.2824 | 0.2122 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0016 | 0.2208 | 0.312 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0016 | 0.2208 | 0.2208 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0045 | 1 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0008 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0016 | 0.2208 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.7075 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.4141 | 1 |
Trypanosoma brucei | unspecified product | 0.0038 | 0.8067 | 0.7878 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.4141 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0016 | 0.2208 | 1 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0016 | 0.2208 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.7075 | 0.6789 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0018 | 0.2824 | 0.2122 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0016 | 0.2208 | 0.2208 |
Echinococcus multilocularis | dna polymerase kappa | 0.0045 | 1 | 1 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0008 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0016 | 0.2208 | 0.1445 |
Toxoplasma gondii | BRCA1 C Terminus (BRCT) domain-containing protein | 0.0012 | 0.1216 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.7075 | 0.6789 |
Onchocerca volvulus | 0.0008 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.2208 | 0.312 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0045 | 1 | 0.5 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0008 | 0 | 0.5 |
Schistosoma mansoni | DNA polymerase eta | 0.0016 | 0.2208 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.